Skip to main navigation Skip to search Skip to main content

Oxaliplatin Elicits Improved Survival in Select Patients with Stage III CRC; Significantly improved survival was observed with oxaliplatin among patients 60 to 70 years of age with stage III CRC, but not those older than 70 years.

Press/Media: Press / Media

Period2025 Aug 22

Media coverage

2

Media coverage